Mark E. Saad - 17 Nov 2021 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Mark E Saad
Issuer symbol
AXSM
Transactions as of
17 Nov 2021
Net transactions value
+$113,922
Form type
4
Filing time
19 Nov 2021, 06:30:28 UTC
Previous filing
08 Jun 2021
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXSM Common Stock Purchase $103,597 +3,000 +43% $34.53 10,002 17 Nov 2021 Direct
transaction AXSM Common Stock Purchase $3,440 +100 $34.40 100 17 Nov 2021 Custodial account for child F1
transaction AXSM Common Stock Purchase $3,445 +100 $34.45 100 17 Nov 2021 Custodial account for child F1
transaction AXSM Common Stock Purchase $3,440 +100 $34.40 100 17 Nov 2021 Custodial account for child F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.